Ningbo No.2 Hospital — Ningbo

Public research footprint of Ningbo No.2 Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Atopic Dermatitis · HR+/HER2+ Early Breast Cancer · Hepatitis B Chronic Infection

Recently updated registry entries

NCT07431827 — MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC… (Recruiting)
NCT04928846 — A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… (Recruiting)
NCT06312137 — A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ningbo No.2 Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.